MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on Wellcare Value Script (S4802-161)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Nevada
Premium
$2.70/month
Deductible
$615.00, doesn't apply to tier 1 and 2
Change plan

6 of 8 Non-statin cholesterol drugs are covered on this plan. 2 of them require prior authorization.

2 aren't on the formulary (Repatha and Nexlizet).

Not on the formulary
Repatha, Nexlizet

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list